secwatch.observer — SEC 8-K summary
======================================

Issuer:     COOPER COMPANIES, INC. (COO)
CIK:        0000711404
Form:       8-K
Filed at:   2022-02-07T23:59:59+00:00
Accession:  0001193125-22-029799
Event type: m_and_a
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CooperCompanies to acquire Cook Medical's Reproductive Health business for $875M
--------------------------------------------------------------------------------

- Deal consideration: $675M at closing plus $200M in four $50M annual installments.
- Cook's Reproductive Health had ~$158M revenue in 2021, up ~17% YoY in constant currency.
- Expected to be accretive to non-GAAP EPS by ~$0.60 in the first year after closing.
- Acquisition enhances CooperSurgical's international fertility footprint and ObGyn device portfolio.
- Closing subject to regulatory approvals, definitive agreement, and local consultation requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/711404/000119312522029799/0001193125-22-029799-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/711404/000119312522029799/d310069d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-029799

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer